Posts Tagged: Israel Betalin Therapeutics
Israel’s Betalin Therapeutics Plans IPO to Fund Diabetes Trials
Israel's Betalin Therapeutics is preparing an initial public offering that will value the biotech firm between $150-170 million to fund trials for its diabetes treatment,...